So-Young International (NASDAQ:SY – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Citigroup in a research note issued on Monday, MarketBeat.com reports. They currently have a $0.80 price objective on the stock, down from their prior price objective of $1.50. Citigroup’s target price would indicate a potential upside of 6.13% from the stock’s current price.
So-Young International Trading Up 2.1 %
Shares of So-Young International stock opened at $0.75 on Monday. So-Young International has a twelve month low of $0.69 and a twelve month high of $1.52. The stock has a market capitalization of $78.04 million, a price-to-earnings ratio of 37.69 and a beta of 0.90. The business’s 50 day simple moving average is $0.87 and its 200-day simple moving average is $1.04.
So-Young International (NASDAQ:SY – Get Free Report) last posted its earnings results on Friday, August 23rd. The company reported $0.02 EPS for the quarter. So-Young International had a return on equity of 1.32% and a net margin of 2.23%. The firm had revenue of $56.06 million for the quarter.
Institutional Trading of So-Young International
So-Young International Company Profile
So-Young International Inc operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com.
Read More
- Five stocks we like better than So-Young International
- What Are Dividend Champions? How to Invest in the Champions
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- The How And Why of Investing in Oil Stocks
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Options Trading – Understanding Strike Price
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for So-Young International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for So-Young International and related companies with MarketBeat.com's FREE daily email newsletter.